Treatment of immune-mediated inflammatory diseases with tumor necrosis factor inhibitors is associated with lower COVID-19 hospitalization and death rates compared to other treatments
1. Immune-mediated inflammatory disease patients treated with tumor necrosis factor (TNF) inhibitor were associated with fewer hospitalizations or deaths due...